Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia
Pediatric MLLT10+ AML have poor prognosis and may benefit from targeted therapies.Patients with PICALM::MLLT10+ and X::MLLT10+ exhibit DNA hypermethylation